![Gerard J. Platenburg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gerard J. Platenburg
Gründer bei PROQR THERAPEUTICS N.V.
Aktive Positionen von Gerard J. Platenburg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PROQR THERAPEUTICS N.V. | Direktor/Vorstandsmitglied | - | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 | - | |
Gründer | 21.02.2012 | - | |
Corporate Officer/Principal | 01.12.2013 | 01.01.2022 |
Karriereverlauf von Gerard J. Platenburg
Ehemalige bekannte Positionen von Gerard J. Platenburg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ISA Pharmaceuticals BV
![]() ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Vorstandsvorsitzender | 01.01.2009 | 01.01.2014 |
PROSENSA HOLDING NV | Vorstandsvorsitzender | 01.04.2002 | 01.05.2009 |
Gründer | 01.04.2002 | 01.05.2009 | |
Pharming NV
![]() Pharming NV Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Pharming NV is a Belgian company that develops therapeutic products for the treatment of a range of medical indications. The company is based in Geel, Belgium. Pharming was acquired by Genzyme Corp., a subsidiary of Sanofi from Pharming Group NV on October 30, 2001. | Corporate Officer/Principal | 01.01.1989 | - |
Ausbildung von Gerard J. Platenburg
University of Leiden | Graduate Degree |
Statistik
International
Niederlande | 5 |
Belgien | 2 |
Operativ
Chief Executive Officer | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PROQR THERAPEUTICS N.V. | Health Technology |
Private Unternehmen | 3 |
---|---|
Prosensa Holding NV
![]() Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
Pharming NV
![]() Pharming NV Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Pharming NV is a Belgian company that develops therapeutic products for the treatment of a range of medical indications. The company is based in Geel, Belgium. Pharming was acquired by Genzyme Corp., a subsidiary of Sanofi from Pharming Group NV on October 30, 2001. | Commercial Services |
ISA Pharmaceuticals BV
![]() ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Health Technology |
- Börse
- Insiders
- Gerard J. Platenburg
- Erfahrung